All publications
Solubility and Stability of Delta-9-Tetrahydrocannabinol in Lipid Excipients
CRS Annual Meeting - virtual - Jul 2021
Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties
CRS Annual Meeting - virtual - Jul 2021
Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 2 Studying impact on dissolution profiles of ER tablets of different API’s
CRS Annual Meeting - virtual - Jul 2021
Selecting efficient pharmaceutical binder for developing robust extended-release matrices of Compritol® 888 ATO prepared using wet granulation technique: Part 1 Studying impact on granule & tablet properties
CRS Annual Meeting - virtual - Jul 2021
GELUCIRE® 4414 for type IV lipid based formulations and their in vitro in vivo performance evaluation
AAPS PharmSci360 – Philadelphia (USA) - 2021
In this study, Gelucire® 44/14 in type IV lipid-based formulation has been evaluated to increase the solubility and in vivo performance of ticagrelor.
Solid lipid nanocarriers to increase oral bioavailability of the peptide Leuprolide
PBP World Meeting - 2021